Morita Lab Contributes a Step Toward Possible New Anti-TB Treatment Path

As part of the long effort to improve treatment of tuberculosis (TB), microbiologists led by Yasu Morita (M2M) report that they have for the first time characterized a protein involved in making a glycolipid compound found in the TB cell wall, which is critical for the disease-causing Mycobacterium to become infectious.